Fundraising Fox博奥晶典
1 known investors
Find your way into 博奥晶典
Sign up to see every warm intro you have to 博奥晶典
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 博奥晶典 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Capital Biotech (博奥晶典) operates a high-throughput biotechnology service platform in China, developing molecular diagnostics products including prenatal screening and diagnostic tests for birth defect prevention. It also provides genetic testing and forensic DNA identification services for public-health and government programs.
Investors · 1
Frequently asked questions
- What does 博奥晶典 do?
- Capital Biotech (博奥晶典) operates a high-throughput biotechnology service platform in China, developing molecular diagnostics products including prenatal screening and diagnostic tests for birth defect prevention. It also provides genetic testing and forensic DNA identification services for public-health and government programs.
- Who are 博奥晶典's investors?
- 博奥晶典's investors include Lang Sheng Investment Group Co. Ltd..